VHP Qualification Protocol
VHP Qualification Protocol
Purpose
To establish a protocol for validating alternative
decontamination agents and systems
Objective
To demonstrate the alternative decon agent/system is at least
as effective as formaldehyde gas
Decontamination Procedure
The methodology for the decontamination procedure during
the validation study should be clearly specified prior to the
study. The protocol should clearly state the method being
validated, i.e. measured concentration/fixed mass
NSF 49 Annex K Overview (contd.)
Measured concentration
methodology validated
Methodology based on established
EPA-registered sterilant validation
data and B&V pre-testing
experiments
STERIS VHP EPA registration
validation data
250 PPM @ 90 minutes
400 PPM @ 30 minutes
VHP Validation Experiments (contd.)
Exhaust Filter BI
Placement
VHP Validation Experiments (contd.)
Cabinet preparation
H2O2
Supply sensor
Filter BI
Placement
VHP Validation Experiments (contd.)
Pre-testing experiments performed on multiple BSC models
20+ runs executed to :
Establish environmental conditions (Temp/RH)
Establish target VHP concentration and identify VHP
monitoring location
Optimize vapor distribution by identifying injection and
return port locations
Establish internal blower operation cycle, as applicable
Establish VHP injection rates
Establish VHP exposure time
VHP Validation Experiments (contd.)
Methodology Conditions:
Start temperature+humidity: > 60 F/< 70% Rh
VHP injected into the downstream (clean) side
of the exhaust HEPA filter with return through
BSC access opening for A1,A2 and B1 and via
cabinet supply intake on B2.
VHP injection rate of 3g/minute, 59% H2O2
VHP injection to > 400 ppm @ center work
surface + 30 minutes continuous VHP injection,
reversing injection/return pathway halfway
through
Where operational operate the BSC blower at a
minimum of one minute for every 15 minutes
of VHP injection
VHP BSC Validation Experiments (contd.)
Study Data
30
25
Average Time to
20 reach 400 ppm:
Minutes
23 Minutes
15
10
0
A1-1
A1-2
A2-1
A2-2
B1-1
B1-2
B2-1
B2-2
BSC Evaluated
VHP BSC Validation Experiments (contd.)
Study Data
Cumulative Injection Time
60
55
50
45
Average Total
40
Minutes
35 Injection Time :
30 53 Minutes
25
20
15
10
5
0
A1-1
A1-2
A2-1
A2-2
B1-1
B1-2
B2-1
B2-2
BSC Evaluated
VHP BSC Validation Experiments (contd.)
Study Data
Average VHP Concentration
600
550
500 Average VHP
450 Concentration:
400
350 475 ppm
ppm
300
250
200
150
100
50
0
A1-1
A1-2
A2-1
A2-2
B1-1
B1-2
B2-1
B2-2
BSC Evaluated
VHP BSC Validation Study BI Sites and Trial
Results
BSC Trial # BI Site Result Trial Result
NuAire, Inc.
The Baker Company
Esco Technologies, Inc.
STERIS Corporation